NewsEuropeSuppliers Selected For Ireland’s Medical Cannabis Pilot

Suppliers Selected For Ireland’s Medical Cannabis Pilot

-

TWO companies have been approved as the first suppliers to Ireland’s recently launched medical cannabis programme.

The Irish Government signed off on the launch of its five-year pilot in June, with Canadian firm Aurora and MGC Pharmaceuticals, of Australia, selected to provide its first cannabis medicine.

Under the scheme consultants can prescribe to patients for spasticity, associated with multiple sclerosis, chemotherapy-related intractable nausea and treatment-resistant epilepsy.

The two products are Aurora High CBD Oil Drops and CannEpil, both are CBD based drugs with the latter being used to treat epilepsy.

However, much like its UK neighbour there will be a time-lag of weeks between prescription and receipt of the drug.

The Irish Journal reports that under the scheme the two companies have to apply for a licence to bring the product into Ireland for distribution. 

CannEpil is a product that ‘has been years in the making’, and was released into the market in 2017, says Roby Zomer, Executive Director and CEO at MGC. 

The Medical Cannabis Access Programme was signed into law in June this year, by Ireland’s Minister for Health, Simon Harris. 

Mr Harris said at the time that the programme would allow ‘compassionate access to cannabis for medical reasons’ in cases where conventional treatment has failed.

The Irish Government says it wants to encourage the development of a home-grown cannabis cultivation and hemp industry saying it the potential to create over 80,000 jobs.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are leading the fight against over-zealous German law enforcement in a...

UK CBD Consumption To Switch From Oils To Capsules – As New Research Estimates Market Value At £690m

CAPSULES are set to replace oils as the preferred method of CBD consumption - as new research show the...

Crowdfunding: An Emerging Capital Greenhouse For The Cannabis Industry

ALPHAGREEN is expected to hit close to the £2m crowdfunding mark on the Seedrs platform by mid-May – double...

Former JP Morgan Banker Lands Two UK Cannabis Jobs

A VETRAN of American investment bank JP Morgan has entered the burgeoning field of cannabis with appointments to two...

Europe’s Hemp Pioneer Posts Record Results With CBD, Construction And Car-Making To The Fore

EUROPEAN pioneer HempFlax has posted record annual results with revenues up 43% to €14.5m (£12.5m) as it returned a...

Sales Up Sharply At Sativa Wellness But Operational Costs Lead to £4.5m Loss

BRITISH CBD firm Sativa Wellness saw annual sales rise by over one-third in an eventful year which saw it...

Must read

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are...

You might also likeRELATED
Recommended to you